Síndrome neuroléptico maligno: aproximación médico-psiquiátrica / Malignant neuroleptic syndrome: a clinical-psychiatric approach
Rev. méd. Chile
; 125(2): 195-9, feb. 1997. graf
Article
in Es
| LILACS
| ID: lil-194818
Responsible library:
CL1.1
ABSTRACT
We report the case of a 42 years old male, with a bipolar disorder and receiving lithium therapy, valproic acid and clonazepam. Due to an exacerbation of his underlying disease, he was admitted to a psychiatric clinic and received 50 mg of intramuscular chlorpromazine in 2 ocasions. Afterwards, the patient had an alteration of conciousness, fever reaching 39ºC and generalized muscular rigidity. Laboratory work-up showed a normal brain CT scan, a diffuse slowness in the EEG and a creatinphosphokinase that reached values of 3.040 U/l. He was transferred to an intensive care unit and treated with sodium dantrolene and bromocriptine, obtaining a good clinical response
Search on Google
Collection:
01-internacional
Database:
LILACS
Main subject:
Chlorpromazine
/
Neuroleptic Malignant Syndrome
Limits:
Adult
/
Humans
/
Male
Language:
Es
Journal:
Rev. méd. Chile
Journal subject:
MEDICINA
Year:
1997
Type:
Article